• Aucun résultat trouvé

PharmaSwiss Choose More

N/A
N/A
Info
Télécharger
Protected

Academic year: 2022

Partager "PharmaSwiss Choose More"

Copied!
1
0
0

Chargement.... (Voir le texte intégral maintenant)

Texte intégral

(1)

1fil: PharmaSwiss

Choose More Life

Orszagos Gyogyszereszeti Intezet H-1051 Budapest Zrinyi u.3 Hungary

TO WHOM IT MAY CONCERN

PharmaSwiss Ceska republika s.r.o.

Jankovcova 1569/2c 170 00, Praha 7 Czech Republic

hereby confirm that data exclusivity period of the reference medicinal product has been expired in Hungary.

Therefore, marketing authorisation application for the pharmaceutical product latanoprost;

0,05 mg/ml; eye drops, solution; DKJH/2754/001/DC, in Hungary does not infringe any data exclusivity rights of third parties in the territory of Hungary.

In Prague, 11.4.201 7

/~

~,_,ft

2

~...fl;-,

/I

.

...

...

...

RNDr. Marketa Strakova Regulatory Affairs Director Europe

PharmaSwiss Czech Republic, Janko\CO\a 1569 ~c, 170 00 Prague 7

registered at Companies Register aclrniniste1·ecl by the 1\ lunicipal Court in Prague, Section C File No. 1J353 i JC0:27448 I 69, D!C:C727448 I 69, bank ..:onnc:ctio1r LlniCreclit Bank. Prague I, account no: 8057600(17 2700

Références

Télécharger maintenant ( PDF - 1 Page - 289.85 KB )

Documents relatifs

Package leaflet: Information for the user [Invented name] 40 micrograms/mL+ 5 mg/mL eye drops, solution

Tell your doctor before you have an operation that you are using [Invented name] as timolol may change effects of some medicines used during anaesthesia.. [Invented name] may

NAME OF THE MEDICINAL PRODUCT [Invented name] 40 micrograms/mL + 5 mg/mL eye drops, solution travoprost/timolol 2

SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN.. Keep out of the sight and reach

[TRAVOPROST + TIMOLOL] 40 MCG/ML + 5 MG/ML, PRESERVATIVE-FREE EYE DROPS, SOLUTION RISK MANAGEMENT PLAN

Five clinical studies were conducted for DuoTrav 40 micrograms/mL + 5 mg/mL eye drops, solution (Alcon Laboratories) to support the efficacy and safety of the

latanoprost; 0,05 mg/ml; eye drops, solution

[r]

NAME OF THE MEDICINAL PRODUCT [Invented name] 50 micrograms/mL eye drops, solution Latanoprost 2

Excipients: Macrogolglycerol hydroxystearate 40, sodium chloride, disodium edetate, sodium dihydrogen phosphate dihydrate, anhydrous disodium phosphate, hydrochloric acid or/and

RISK MANAGEMENT PLAN [LATANOPROST] 50 MCG/ML PRESERVATIVE FREE EYE DROPS, SOLUTION

[LATANOPROST] 50 mcg/ml preservative free eye drops, solution is indicated for thereduction of elevated intraocular pressure in patients with open angle glaucoma and

Decentralized Procedure DK/H/2754/001/DC UUID: 4dfb4ba4-f07d-4e39-8615-5201078dfe31 Vizilatan 0,05 mg/ml; eye drops, solution

[r]

NAME OF THE MEDICINAL PRODUCT [Invented name] 0.3 mg/mL + 5 mg/mL eye drops, solution bimatoprost/timolol 2

SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN.. Keep out of the sight and reach